We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Voluntary surveillance of paediatric bacteraemia in England.
The characteristics, management and surveillance of Gram-negative bacteria such as Escherichia coli, Klebsiella and Pseudomonas aeruginosa.
Among HIV-infected individuals with chronic, non-specific symptoms and negative sputum smear microscopy
This study collected cattle, goat, and poultry meat pathway samples in Tanzania and isolated Salmonella using standard methods
The characteristics, diagnosis, management, surveillance and epidemiology of Klebsiella species.
Annual reports on voluntary surveillance of candida species blood infections in England, Wales and Northern Ireland.
Antibiotic resistance is once again on the rise after declines in the pandemic, with more dangerous strains of bacteria spreading in communities and hospitals.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (30 January 2024) approved the medicine momelotinib (Omjjara) to treat the symptoms experienced by adult myelofibrosis patients who have moderate or severe anaemia (a low number of red blood cells...
The characteristics, diagnosis and management of Candida auris (C. auris).
The study aims to estimate the prevalence of human brucellosis, identify the Brucella spp. causing illness and describe non-Brucella bloodstream infections
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
The Department is introducing a mandatory requirement for all NHS acute trusts to report E.coli bloodstream infections diagnosed after 1 June 2011.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.